Kenvue Inc. (KVUE)

Kenvue Inc. is trading at $19.31, down 1.28% on the session. The 50 day average sits at $18.41 and the 200 day at $18.19, which puts the stock in a uptrend. RSI is at 60, which reads as strong, and MACD is bullish crossover. Volume is volume spike.

The nearest support is around $18.65 with resistance near $19.56, so that band frames the current range. Average daily movement is roughly $0.38, or about 2.0% of the share price, which is what any stop placement has to allow for. The overall health score of 90 out of 100 combines a trend score of 93, momentum of 92 and a risk score of 83.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.